SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), focused on the development of DNA vaccines using its electroporation-based DNA delivery technology, announced today that Dr. Avtar Dhillon, president and CEO, will present a corporate overview on Inovio at BIO InvestorForum 2007, Wednesday, October 10th, at 3:45 p.m. PDT (6:45 p.m. EDT). The conference will be held in San Francisco, October 9-11, 2007.
